Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Income from Non-Controlling Interests (2020 - 2025)

Historic Income from Non-Controlling Interests for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$8000.0.

  • Barinthus Biotherapeutics' Income from Non-Controlling Interests rose 4666.67% to -$8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$64000.0, marking a year-over-year decrease of 1636.36%. This contributed to the annual value of -$109000.0 for FY2024, which is 900.0% down from last year.
  • Barinthus Biotherapeutics' Income from Non-Controlling Interests amounted to -$8000.0 in Q3 2025, which was up 4666.67% from $5000.0 recorded in Q2 2025.
  • Barinthus Biotherapeutics' Income from Non-Controlling Interests' 5-year high stood at $5000.0 during Q2 2025, with a 5-year trough of -$118000.0 in Q1 2021.
  • In the last 5 years, Barinthus Biotherapeutics' Income from Non-Controlling Interests had a median value of -$22000.0 in 2022 and averaged -$32157.9.
  • As far as peak fluctuations go, Barinthus Biotherapeutics' Income from Non-Controlling Interests tumbled by 180000.0% in 2024, and later skyrocketed by 14166.67% in 2025.
  • Barinthus Biotherapeutics' Income from Non-Controlling Interests (Quarter) stood at -$58000.0 in 2021, then plummeted by 46.55% to -$85000.0 in 2022, then skyrocketed by 103.53% to $3000.0 in 2023, then plummeted by 1800.0% to -$51000.0 in 2024, then surged by 84.31% to -$8000.0 in 2025.
  • Its Income from Non-Controlling Interests was -$8000.0 in Q3 2025, compared to $5000.0 in Q2 2025 and -$10000.0 in Q1 2025.